Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Tolerability of Long-Term Administration of Hydromorphone HCI CR (Controlled Release)

This study has been completed.
Information provided by:
Alza Corporation, DE, USA Identifier:
First received: December 12, 2006
Last updated: April 26, 2010
Last verified: April 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2000
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by Identifier (NCT Number):